Market Closed -
Other stock markets
|
After market 19:00:06 | |||
310.7 USD | -0.10% |
|
313 | +0.74% |
07-02 | Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints | MT |
06-27 | Argus Raises Amgen's Price Target to $340 From $300 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.87% | 167B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
-3.33% | 160B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Transcript : Amgen Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-08-2013 09